Viewing Study NCT00722293


Ignite Creation Date: 2025-12-25 @ 1:24 AM
Ignite Modification Date: 2026-02-23 @ 8:06 PM
Study NCT ID: NCT00722293
Status: COMPLETED
Last Update Posted: 2017-11-13
First Post: 2008-07-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase I, Open-label, Study of Pazopanib in Combination With Epirubicin or Doxorubicin for Advanced Solid Tumors
Sponsor: GlaxoSmithKline
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module